Musculoskeletal Manifestations of Inflammatory Bowel Disease

被引:56
作者
Bourikas, Leonidas A. [1 ]
Papadakis, Konstantinos A. [1 ]
机构
[1] Univ Crete, Fac Med, Div Gastroenterol, Univ Hosp Heraklion,Med Sch,Dept Gastroenterol, Iraklion, Crete, Greece
关键词
musculoskeletal manifestations; intestinal inflammation; inflammatory bowel disease; POPULATION-BASED COHORT; CROHNS-DISEASE; ANKYLOSING-SPONDYLITIS; ULCERATIVE-COLITIS; EXTRAINTESTINAL MANIFESTATIONS; RHEUMATOID-ARTHRITIS; ORBITAL MYOSITIS; SERONEGATIVE SPONDYLARTHROPATHIES; CITRULLINATED PROTEINS; GASTROCNEMIUS MYOSITIS;
D O I
10.1002/ibd.20942
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Extraintestinal manifestations develop in approximate to 25% of patients with inflammatory bowel disease (IBD). Musculoskeletal symptoms are the most common extraintestinal manifestations of IBD, often associated with colonic involvement, and present as either articular (arthritis) or periarticular inflammation including enthesitis, myositis, or soft tissue rheumatism (fibromyalgia). Musculoskeletal manifestations can precede or be synchronous with the development of bowel disease or develop following the diagnosis of IBD. Their clinical course often correlates with IBD activity but it can also be independent of the activity of bowel disease. Controlling intestinal inflammation remains the cornerstone therapeutic approach for the musculoskeletal manifestations of IBD.
引用
收藏
页码:1915 / 1924
页数:10
相关论文
共 83 条
[41]  
Heuss D, 1996, CLIN NEUROPATHOL, V15, P150
[42]   Development of Extraintestinal Manifestations in Pediatric Patients with Inflammatory Bowel Disease [J].
Jose, Folashade Adebisi ;
Garnett, Elizabeth A. ;
Vittinghoff, Eric ;
Ferry, George D. ;
Winter, Harland S. ;
Baldossano, Robert N. ;
Kirschner, Barbara S. ;
Cohen, Stanley A. ;
Gold, Benjamin D. ;
Abramson, Oren ;
Heyman, Melvin B. .
INFLAMMATORY BOWEL DISEASES, 2009, 15 (01) :63-68
[43]  
KANEOKA H, 1990, J RHEUMATOL, V17, P275
[44]  
KIDD BL, 1988, BRIT J RHEUMATOL, V27, P230
[45]   High prevalence of osteoporotic vertebral fractures in patients with Crohn's disease [J].
Klaus, J ;
Armbrecht, G ;
Steinkamp, M ;
Brückel, J ;
Rieber, A ;
Adler, G ;
Reinshagen, M ;
Felsenberg, D ;
von Tirpitz, C .
GUT, 2002, 51 (05) :654-658
[46]   Antibodies against cyclic citrullinated peptide (CCP) in inflammatory bowel disease patients with or without arthritic manifestations [J].
Koutroubakis, Ioannis E. ;
Karmiris, Konstantinos ;
Bourikas, Leonidas ;
Kouroumalis, Elias A. ;
Drygiannakis, Ioannis ;
Drygiannakis, Dimitrios .
INFLAMMATORY BOWEL DISEASES, 2007, 13 (04) :504-505
[47]   Inflammatory myositis in association with inflammatory bowel disease [J].
Kulkarni, A ;
Ravi, TJ ;
Brodmerkel, GJ ;
Agrawal, RM .
DIGESTIVE DISEASES AND SCIENCES, 1997, 42 (06) :1142-1145
[48]  
Kull E, 2002, GASTROEN CLIN BIOL, V26, P367
[49]   DERMATOMYOSITIS ASSOCIATED WITH CROHNS-DISEASE [J].
LEIBOWITZ, G ;
ELIAKIM, R ;
AMIR, G ;
RACHMILEWITZ, D .
JOURNAL OF CLINICAL GASTROENTEROLOGY, 1994, 18 (01) :48-52
[50]   Long-term fracture risk in patients with Crohn's disease: A population-based study in Olmsted County, Minnesota [J].
Loftus, EV ;
Crowson, CS ;
Sandborn, WJ ;
Tremaine, WJ ;
O'Fallon, WM ;
Melton, LJ .
GASTROENTEROLOGY, 2002, 123 (02) :468-475